pI: 6.3282 |
Length (AA): 567 |
MW (Da): 61175 |
Paralog Number:
3
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 12
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
114 | 244 | 4ybq (A) | 8 | 157 | 17.00 | 0 | 0.05 | 0.378941 | -0.09 |
147 | 540 | 4tph (A) | 40 | 490 | 17.00 | 0 | 0.6 | 0.679785 | 0.72 |
167 | 536 | 5c65 (A) | 73 | 451 | 25.00 | 0 | 0.88 | 0.802357 | 0.38 |
335 | 426 | 4rfs (S) | 90 | 184 | 33.00 | 0.71 | 0.04 | 0.256058 | 1.4 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_129633)
Species | Accession | Gene Product |
---|---|---|
Dictyostelium discoideum | DDB_G0286151 | hypothetical protein |
Dictyostelium discoideum | DDB_G0281155 | sugar transporter family protein |
Dictyostelium discoideum | DDB_G0277773 | solute carrier family 2 member protein |
Dictyostelium discoideum | DDB_G0292814 | calmodulin-binding protein |
Leishmania braziliensis | LbrM.35.6480 | lmgt2, putative |
Leishmania braziliensis | LbrM.35.6490 | glucose transporter, lmgt2 |
Leishmania braziliensis | LbrM.33.0290 | glucose transporter/membrane transporter D2, putative |
Leishmania donovani | LdBPK_366560.1 | glucose transporter 1 |
Leishmania donovani | LdBPK_366540.1 | glucose transporter 3, putative |
Leishmania donovani | LdBPK_330310.1 | glucose transporter/membrane transporter D2, putative |
Leishmania infantum | LinJ.33.0310 | glucose transporter/membrane transporter D2, putative |
Leishmania infantum | LinJ.36.6540 | glucose transporter, lmgt3 |
Leishmania infantum | LinJ.36.6560 | glucose transporter, lmgt1 |
Leishmania infantum | LinJ.36.6550 | glucose transporter, lmgt2 |
Leishmania major | LmjF.33.0290 | glucose transporter/membrane transporter D2, putative |
Leishmania major | LmjF.36.6300 | glucose transporter, lmgt1 |
Leishmania major | LmjF.36.6280 | glucose transporter, lmgt3 |
Leishmania major | LmjF.36.6290 | glucose transporter, lmgt2 |
Leishmania mexicana | LmxM.32.0290 | glucose transporter/membrane transporter D2, putative |
Leishmania mexicana | LmxM.36.6300 | glucose transporter, lmgt1 |
Leishmania mexicana | LmxM.36.6280 | glucose transporter, lmgt3 |
Leishmania mexicana | LmxM.36.6290 | glucose transporter, lmgt2 |
Trypanosoma brucei gambiense | Tbg972.10.10290 | hexose transporter,glucose transporter 1B, putative |
Trypanosoma brucei gambiense | Tbg972.4.2260 | glucose transporter, putative |
Trypanosoma brucei gambiense | Tbg972.10.10310 | glucose transporter |
Trypanosoma brucei gambiense | Tbg972.10.10300 | glucose transporter,glucose transporter 2A, putative |
Trypanosoma brucei gambiense | Tbg972.10.10280 | hexose transporter,glucose transporter 1B |
Trypanosoma brucei | Tb11.v5.0307 | THT1 - hexose transporter, putative |
Trypanosoma brucei | Tb927.10.8500 | glucose transporter, putative |
Trypanosoma brucei | Tb927.10.8490 | glucose transporter, putative |
Trypanosoma brucei | Tb927.10.8510 | glucose transporter, putative |
Trypanosoma brucei | Tb927.10.8460 | glucose transporter, putative |
Trypanosoma brucei | Tb927.10.8480 | glucose transporter, putative |
Trypanosoma brucei | Tb927.10.8520 | glucose transporter, putative |
Trypanosoma brucei | Tb927.10.8530 | glucose transporter 2A |
Trypanosoma brucei | Tb11.v5.0310 | THT1 - hexose transporter, putative |
Trypanosoma brucei | Tb11.v5.0330 | THT1 - hexose transporter, putative |
Trypanosoma brucei | Tb927.4.2290 | glucose transporter, putative |
Trypanosoma brucei | Tb927.10.8450 | glucose transporter 1E |
Trypanosoma brucei | Tb927.10.8470 | glucose transporter, putative |
Trypanosoma congolense | TcIL3000_4_2100 | glucose transporter, putative |
Trypanosoma congolense | TcIL3000_10_7320 | glucose transporter 2A, putative |
Trypanosoma congolense | TcIL3000_10_7310 | glucose transporter, putative |
Trypanosoma cruzi | TcCLB.511041.40 | hexose transporter, putative |
Trypanosoma cruzi | TcCLB.506355.10 | hexose transporter |
Trypanosoma cruzi | TcCLB.508551.39 | hexose transporter, putative |
Trypanosoma cruzi | TcCLB.506355.5 | hexose transporter, putative |
Trypanosoma cruzi | TcCLB.508551.30 | hexose transporter, putative |
Trichomonas vaginalis | TVAG_247420 | glucose transporter, putative |
Trichomonas vaginalis | TVAG_039990 | sugar transporter, putative |
Trichomonas vaginalis | TVAG_040000 | glucose transporter, putative |
Trichomonas vaginalis | TVAG_039960 | sugar transporter, putative |
Trichomonas vaginalis | TVAG_039970 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_037050 | sugar transporter, putative |
Trichomonas vaginalis | TVAG_495680 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.4.2290 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.4.2290 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.4.2290 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.4.2290 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.10.8530 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.8530 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.8530 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.8530 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.10.8440 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.8440 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.8440 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.8440 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Rattus norvegicus | Solute carrier family 2, facilitated glucose transporter member 1 | 492 aa | 24.0% | 404 aa | Compounds | References |